Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07676617 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Satisfaction of Patients With Erectile Dysfunction With the Use of Sildenafil Oral Suspension Compared to Orodispersible Tablets

Study acronym: SILOROS
StatusCompleted
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Lead sponsor: Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico to Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico Show 4 more changesShow less
    • Trial completed
    • Eligibility criteria expanded, about 14 words
    • Site details revised
    • Study description expanded, about 4 words
  2. Primary endpoint(s) modifiedv2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The goal of this observational retrospective study is to to evaluate treatment satisfaction with sildenafil oral suspension in patients with mild-to-moderate ED who were previously taking orodispersible sildenafil. The secondary objective is to evaluate the efficacy and side effects of therapy with sildenafil oral suspension compared to orodispersible sildenafil. Patients who took sildenafil orodispersible 50 mg for 3 months and subsequently took sildenafil oral suspension for another 3 months will be enrolled.
Trial Details
NCT Number NCT07676617
Lead Sponsor Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
Conditions
(from sponsor)		 Erectile Dysfunction, Erectile Dysfunction (ED)
Related terms Erectile Dysfunction
Enrollment 55 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov